Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan P Whitehead

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Canadian Journal of Physiology and Pharmacology|June 11, 2013
The effect of 25-hydroxyvitamin D on insulin sensitivity in obesity: is it mediated via adiponectin?Olivia R L Wright, Ingrid J Hickman, William G Petchey, et al.
Biochemical and Biophysical Research Communications|June 16, 2009
Inhibition of inosine monophosphate dehydrogenase reduces adipogenesis and diet-induced obesityHua Su, Jennifer H Gunter, Melissa de Vries, et al.
General and Comparative Endocrinology|May 3, 2011
Adiponectin profiles are affected by chronic and acute changes in carbohydrate intake in healthy catsHeok Yit Tan, Jacquie S Rand, John M Morton, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 15, 2018
Iron Inhibits the Secretion of Apolipoprotein E in Cultured Human AdipocytesL J Britton, Kim Bridle, Lesley-Anne Jaskowski, et al.
Molecular Endocrinology (Baltimore, Md.)|October 27, 2009
Sialic acid modification of adiponectin is not required for multimerization or secretion but determines half-life in circulationAyanthi A Richards, Michelle L Colgrave, Jialiang Zhang, et al.
Diabetes|December 22, 2011
Identification of BMP and activin membrane-bound inhibitor (BAMBI) as a potent negative regulator of adipogenesis and modulator of autocrine/paracrine adipogenic factorsXiao Luo, Louise J Hutley, Julie A Webster, et al.
Nature Medicine|November 3, 2014
Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stressSumaira Z Hasnain, Danielle J Borg, Brooke E Harcourt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 4, 2014
Resveratrol does not benefit patients with nonalcoholic fatty liver diseaseVeronique S Chachay, Graeme A Macdonald, Jennifer H Martin, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Canadian Journal of Physiology and Pharmacology|June 11, 2013
The effect of 25-hydroxyvitamin D on insulin sensitivity in obesity: is it mediated via adiponectin?Olivia R L Wright, Ingrid J Hickman, William G Petchey, et al.
Biochemical and Biophysical Research Communications|June 16, 2009
Inhibition of inosine monophosphate dehydrogenase reduces adipogenesis and diet-induced obesityHua Su, Jennifer H Gunter, Melissa de Vries, et al.
General and Comparative Endocrinology|May 3, 2011
Adiponectin profiles are affected by chronic and acute changes in carbohydrate intake in healthy catsHeok Yit Tan, Jacquie S Rand, John M Morton, et al.
Cellular and Molecular Gastroenterology and Hepatology|August 15, 2018
Iron Inhibits the Secretion of Apolipoprotein E in Cultured Human AdipocytesL J Britton, Kim Bridle, Lesley-Anne Jaskowski, et al.
Molecular Endocrinology (Baltimore, Md.)|October 27, 2009
Sialic acid modification of adiponectin is not required for multimerization or secretion but determines half-life in circulationAyanthi A Richards, Michelle L Colgrave, Jialiang Zhang, et al.
Diabetes|December 22, 2011
Identification of BMP and activin membrane-bound inhibitor (BAMBI) as a potent negative regulator of adipogenesis and modulator of autocrine/paracrine adipogenic factorsXiao Luo, Louise J Hutley, Julie A Webster, et al.
Nature Medicine|November 3, 2014
Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stressSumaira Z Hasnain, Danielle J Borg, Brooke E Harcourt, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 4, 2014
Resveratrol does not benefit patients with nonalcoholic fatty liver diseaseVeronique S Chachay, Graeme A Macdonald, Jennifer H Martin, et al.
Pageof 5